EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+29.65%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Top Buys
| 1 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$3.5M |
| 2 |
Weibo
WB
|
$2.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$1.88M |
| 4 |
Deckers Outdoor
DECK
|
$1.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
$1.55M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$20.3M |
| 2 |
Yum China
YUMC
|
$12.8M |
| 3 |
Pinduoduo
PDD
|
$10.6M |
| 4 |
TSMC
TSM
|
$9.64M |
| 5 |
Apple
AAPL
|
$4.98M |
Sector Composition
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Replimune Group
REPL
$494M
| $209K | 0.01% |
+24,739
| New | +$209K |
|
277
Mirum Pharmaceuticals
MIRM
$3.82B
| $207K | 0.01% |
7,001
-49
| -0.7% | -$1.45K |
|
278
Travere Therapeutics
TVTX
$1.93B
| $206K | 0.01% |
22,910
+4,314
| +23% | +$38.8K |
|
279
Protagonist Therapeutics
PTGX
$3.77B
| $205K | 0.01% |
8,957
-9,034
| -50% | -$207K |
|
280
Caterpillar
CAT
$198B
| $204K | 0.01% |
690
-107
| -13% | -$31.6K |
|
281
Mettler-Toledo International
MTD
$26.9B
| $203K | 0.01% |
+167
| New | +$203K |
|
282
Vericel Corp
VCEL
$1.72B
| $202K | 0.01% |
5,683
-750
| -12% | -$26.7K |
|
283
Union Pacific
UNP
$131B
| $202K | 0.01% |
+823
| New | +$202K |
|
284
Centene
CNC
$14.2B
| $200K | 0.01% |
+2,700
| New | +$200K |
|
285
Boeing
BA
$174B
| $200K | 0.01% |
+768
| New | +$200K |
|
286
ImmunityBio
IBRX
$2.27B
| $198K | 0.01% |
+39,494
| New | +$198K |
|
287
Editas Medicine
EDIT
$248M
| $194K | 0.01% |
19,134
-6,321
| -25% | -$64K |
|
288
Relay Therapeutics
RLAY
$710M
| $193K | 0.01% |
17,486
-1,917
| -10% | -$21.1K |
|
289
Geron
GERN
$893M
| $189K | 0.01% |
89,633
-8,075
| -8% | -$17K |
|
290
Hewlett Packard
HPE
$31B
| $185K | 0.01% |
10,915
-811
| -7% | -$13.8K |
|
291
Day One Biopharmaceuticals
DAWN
$773M
| $184K | 0.01% |
12,618
+442
| +4% | +$6.45K |
|
292
SiriusXM
SIRI
$8.1B
| $181K | 0.01% |
3,304
-321
| -9% | -$17.6K |
|
293
Viatris
VTRS
$12.2B
| $179K | 0.01% |
16,562
+5,921
| +56% | +$64.1K |
|
294
MannKind Corp
MNKD
$1.7B
| $159K | 0.01% |
43,621
-334
| -0.8% | -$1.22K |
|
295
uniQure
QURE
$985M
| $133K | 0.01% |
19,687
-388
| -2% | -$2.63K |
|
|
CDMO
296
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $132K | 0.01% |
+20,349
| New | +$132K |
|
297
ADMA Biologics
ADMA
$4.03B
| $131K | 0.01% |
29,060
-3,069
| -10% | -$13.9K |
|
298
CareDx
CDNA
$736M
| $122K | 0.01% |
10,165
-5,518
| -35% | -$66.2K |
|
299
Caribou Biosciences
CRBU
$174M
| $117K | 0.01% |
20,351
-5,714
| -22% | -$32.7K |
|
300
Anavex Life Sciences
AVXL
$807M
| $115K | 0.01% |
12,388
-1,520
| -11% | -$14.2K |
|